{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:31:42Z","timestamp":1783971102709,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Innovation Group Project of Shanghai Municipal Health Commission","award":["2019CXJQ03"],"award-info":[{"award-number":["2019CXJQ03"]}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and technology development fund","doi-asserted-by":"crossref","award":["19MC1911000"],"award-info":[{"award-number":["19MC1911000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Municipal Key Clinical Specialty","award":["shslczdzk01301"],"award-info":[{"award-number":["shslczdzk01301"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00432-021-03696-2","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T22:02:36Z","timestamp":1626127356000},"page":"2935-2944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Germline and tumor BRCA1\/2 pathogenic variants in Chinese triple-negative breast carcinomas"],"prefix":"10.1007","volume":"147","author":[{"given":"Gang","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longlong","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"key":"3696_CR1","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13:674\u2013690. https:\/\/doi.org\/10.1038\/nrclinonc.2016.66","journal-title":"Nat Rev Clin Oncol"},{"key":"3696_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/jpm10020041","volume":"10","author":"S Boussios","year":"2020","unstructured":"Boussios S et al (2020) Wise management of ovarian cancer: on the cutting edge. J Pers Med 10:41. https:\/\/doi.org\/10.3390\/jpm10020041","journal-title":"J Pers Med"},{"key":"3696_CR3","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.annonc.2020.09.010","volume":"31","author":"F Cardoso","year":"2020","unstructured":"Cardoso F et al (2020) 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol 31:1623\u20131649. https:\/\/doi.org\/10.1016\/j.annonc.2020.09.010","journal-title":"Ann Oncol"},{"key":"3696_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ et al (2015) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33:304\u2013311. https:\/\/doi.org\/10.1200\/JCO.2014.57.1414","journal-title":"J Clin Oncol"},{"key":"3696_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","volume":"18","author":"MB Daly","year":"2020","unstructured":"Daly MB et al (2020) NCCN Guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020. J Natl Compr Canc Netw 18:380\u2013391. https:\/\/doi.org\/10.6004\/jnccn.2020.0017","journal-title":"J Natl Compr Canc Netw"},{"key":"3696_CR6","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","volume":"389","author":"C Denkert","year":"2017","unstructured":"Denkert C, Liedtke C, Tutt A, von Minckwitz G (2017) Molecular alterations in triple-negative breast cancer-the road to new treatment strategies. Lancet 389:2430\u20132442. https:\/\/doi.org\/10.1016\/S0140-6736(16)32454-0","journal-title":"Lancet"},{"key":"3696_CR7","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-10-2560","volume":"17","author":"AM Gonzalez-Angulo","year":"2011","unstructured":"Gonzalez-Angulo AM et al (2011) Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin Cancer Res 17:1082\u20131089. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-2560","journal-title":"Clin Cancer Res"},{"key":"3696_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mgg3.157","volume":"3","author":"Y Hirotsu","year":"2015","unstructured":"Hirotsu Y, Nakagomi H, Sakamoto I, Amemiya K, Oyama T, Mochizuki H, Omata M (2015) Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer. Mol Genet Genomic Med 3:459\u2013466. https:\/\/doi.org\/10.1002\/mgg3.157","journal-title":"Mol Genet Genomic Med"},{"key":"3696_CR9","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402\u20132416. https:\/\/doi.org\/10.1001\/jama.2017.7112","journal-title":"JAMA"},{"key":"3696_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ijc.30692","volume":"141","author":"GT Lang","year":"2017","unstructured":"Lang GT et al (2017) The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: screening of 2991 patients and 1043 controls by next-generation sequencing. Int J Cancer 141:129\u2013142. https:\/\/doi.org\/10.1002\/ijc.30692","journal-title":"Int J Cancer"},{"key":"3696_CR11","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00432-017-2465-8","volume":"143","author":"G Li","year":"2017","unstructured":"Li G et al (2017) Analysis of BRCA1\/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing. J Cancer Res Clin Oncol 143:2011\u20132024. https:\/\/doi.org\/10.1007\/s00432-017-2465-8","journal-title":"J Cancer Res Clin Oncol"},{"key":"3696_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66\u201371. https:\/\/doi.org\/10.1126\/science.7545954","journal-title":"Science"},{"key":"3696_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa070608","volume":"357","author":"G Rennert","year":"2007","unstructured":"Rennert G, Bisland-Naggan S, Barnett-Griness O, Bar-Joseph N, Zhang S, Rennert HS, Narod SA (2007) Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 357:115\u2013123. https:\/\/doi.org\/10.1056\/NEJMoa070608","journal-title":"N Engl J Med"},{"key":"3696_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"3696_CR15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jnci\/djy106","volume":"110","author":"H Shimelis","year":"2018","unstructured":"Shimelis H et al (2018) Triple-negative breast cancer risk genes identified by multigene hereditary cancer panel testing. J Natl Cancer Inst 110:855\u2013862. https:\/\/doi.org\/10.1093\/jnci\/djy106","journal-title":"J Natl Cancer Inst"},{"key":"3696_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/cge.13256","volume":"94","author":"L Su","year":"2018","unstructured":"Su L et al (2018) Prevalence of BRCA1\/2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancer. Clin Genet 94:165\u2013169. https:\/\/doi.org\/10.1111\/cge.13256","journal-title":"Clin Genet"},{"key":"3696_CR17","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1158\/1078-0432.CCR-16-3227","volume":"23","author":"J Sun","year":"2017","unstructured":"Sun J et al (2017) Germline mutations in cancer susceptibility genes in a large series of unselected breast cancer patients. Clin Cancer Res 23:6113\u20136119. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3227","journal-title":"Clin Cancer Res"},{"key":"3696_CR18","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3390\/cancers12051252","volume":"12","author":"A Toss","year":"2020","unstructured":"Toss A et al (2020) BRCA detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: when biology overcomes genealogy. Cancers (basel) 12:1252. https:\/\/doi.org\/10.3390\/cancers12051252","journal-title":"Cancers (basel)"},{"key":"3696_CR19","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41591-018-0009-7","volume":"24","author":"A Tutt","year":"2018","unstructured":"Tutt A et al (2018) Carboplatin in BRCA1\/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. Nat Med 24:628\u2013637. https:\/\/doi.org\/10.1038\/s41591-018-0009-7","journal-title":"Nat Med"},{"key":"3696_CR20","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/annonc\/mdw209","volume":"27","author":"C Winter","year":"2016","unstructured":"Winter C et al (2016) Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic. Ann Oncol 27:1532\u20131538. https:\/\/doi.org\/10.1093\/annonc\/mdw209","journal-title":"Ann Oncol"},{"key":"3696_CR21","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","volume":"36","author":"AC Wolff","year":"2018","unstructured":"Wolff AC et al (2018) Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update. J Clin Oncol 36:2105\u20132122. https:\/\/doi.org\/10.1200\/JCO.2018.77.8738","journal-title":"J Clin Oncol"},{"key":"3696_CR22","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1126\/science.8091231","volume":"265","author":"R Wooster","year":"1994","unstructured":"Wooster R et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12\u201313. Science 265:2088\u20132090. https:\/\/doi.org\/10.1126\/science.8091231","journal-title":"Science"},{"key":"3696_CR23","doi-asserted-by":"publisher","first-page":"e1229","DOI":"10.1016\/j.clbc.2017.12.014","volume":"18","author":"S Yadav","year":"2018","unstructured":"Yadav S et al (2018) Impact of BRCA mutation status on survival of women with triple-negative breast cancer. Clin Breast Cancer 18:e1229\u2013e1235. https:\/\/doi.org\/10.1016\/j.clbc.2017.12.014","journal-title":"Clin Breast Cancer"},{"key":"3696_CR24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nrg3317","volume":"13","author":"LR Yates","year":"2012","unstructured":"Yates LR, Campbell PJ (2012) Evolution of the cancer genome. Nat Rev Genet 13:795\u2013806. https:\/\/doi.org\/10.1038\/nrg3317","journal-title":"Nat Rev Genet"},{"key":"3696_CR25","doi-asserted-by":"publisher","first-page":"e0156789","DOI":"10.1371\/journal.pone.0156789","volume":"11","author":"X Zhong","year":"2016","unstructured":"Zhong X et al (2016) Prevalence and prognostic role of BRCA1\/2 variants in unselected chinese breast cancer patients. PLoS ONE 11:e0156789. https:\/\/doi.org\/10.1371\/journal.pone.0156789","journal-title":"PLoS ONE"},{"key":"3696_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/1759-7714.12426","volume":"8","author":"TT Zuo","year":"2017","unstructured":"Zuo TT, Zheng RS, Zeng HM, Zhang SW, Chen WQ (2017) Female breast cancer incidence and mortality in China, 2013. Thorac Cancer 8:214\u2013218. https:\/\/doi.org\/10.1111\/1759-7714.12426","journal-title":"Thorac Cancer"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03696-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-021-03696-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03696-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T11:15:44Z","timestamp":1630062944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-021-03696-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["3696"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03696-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-262082\/v1","asserted-by":"object"}]},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,13]]},"assertion":[{"value":"20 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by Medical Ethics Committee of Fudan University Shanghai Cancer Center (Shanghai, China).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}